Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)

Richard0623

Richard0623
Send Message
View as an RSS Feed
View Richard0623's Comments BY TICKER:
Latest  |  Highest rated
  • After-hours top gainers, as of 5:15 p.m.: AZC +9%. ORI +6%. JASO +5%. THD +4%. CAW +4%.
    After-hours top losers: NBG -2%. GDXJ -2%. KGC -2%. BYD -2%. AG -2%[View news story]
    What about AFFY?
    May 31 05:57 PM | Likes Like |Link to Comment
  • Affymax Is Still Alive [View article]
    Here's to hoping you rode the wave and sold today before the market closed
    May 31 04:54 PM | Likes Like |Link to Comment
  • Dendreon Shocks Market With Provenge Sales Decline In Q1 [View article]
    Horrible numbers, incredibly disappointing. What a waste of a company that once had a bright future and great product
    May 9 05:02 PM | Likes Like |Link to Comment
  • Arlington Asset Investment Corp. Declares $0.875 per Share Dividend for the First Quarter of 2013 [View article]
    Pretty wild. Anyone see them being able to maintain their payout?
    Mar 16 12:12 PM | Likes Like |Link to Comment
  • Einhorn's Apple (AAPL) proposal is pretty much the stub stock idea made famous by Joel Greenblatt, writes The Brooklyn Investor, showing how issuing $50B in preferred would theoretically add $32/share in value. In cases where an underleveraged firm won't lever up, Greenblatt reminded an investor can and should create their own leverage using LEAPs. This spreadsheet (from May) on Greenlight's site details Einhorn's preferred idea for not just Apple, but DELL, GM, MRVL, and MSFT[View news story]
    Apple should just continue to build it's cash pile and then take itself private. All these headaches from the insane media attention and shareholders. They are banking over $50B in Net Profit each year and certainly don't need public owners for raising funds.
    Feb 10 07:50 PM | 7 Likes Like |Link to Comment
  • USA Graphite: Why This $100 Million Company Could Fall By 85% Or More [View article]
    What are you talking about, your posts are right there
    Feb 6 12:11 PM | Likes Like |Link to Comment
  • Savient Pharma: Still Struggling To Grow KRYSTEXXA Sales [View article]
    If only it were that simple.
    Nov 21 12:34 PM | 1 Like Like |Link to Comment
COMMENTS STATS
7 Comments
8 Likes